Crossmark

Optimization of the treatment with beta-lactam antibiotics in critically ill patients—guidelines from the French Society of Pharmacology and Therapeutics (Société Française de Pharmacologie et Thérapeutique—SFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Société Française d’Anesthésie et Réanimation—SFAR)

Crossref DOI link: https://doi.org/10.1186/s13054-019-2378-9

Published Online: 2019-03-29

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Guilhaumou, Romain

Benaboud, Sihem

Bennis, Youssef

Dahyot-Fizelier, Claire

Dailly, Eric

Gandia, Peggy

Goutelle, Sylvain

Lefeuvre, Sandrine

Mongardon, Nicolas

Roger, Claire

Scala-Bertola, Julien

Lemaitre, Florian

Garnier, Marc http://orcid.org/0000-0002-5716-4239
License Information

Text and Data Mining valid from 2019-03-29
More Information

Article History

Received: 21 November 2018

Accepted: 26 February 2019

First Online: 29 March 2019

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: RG: travel expenses borne by MSD, Sanofi and Pfizer. CR: travel expenses borne by MSD and Pfizer. The remaining authors declare that they have no competing interest.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below